Placental progesterone biosynthesis in preterm pregnancy
Placental progesterone biosynthesis in preterm pregnancy
批准号:
7117014
负责人:
Eileen Yee Wang
金额:
$0.98万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2005
资助国家:
美国
项目状态:
已结题
起止时间:
2005-09-01 至 2007-11-30
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Progesterone (P) maintains uterine quiescence in pregnancy, as evidenced by the observation that the onset of labor in most mammals occurs following a drop in maternal P. Though no measurable decrease in human P is noted with the onset of labor, two recent randomized, double-blind, placebo-controlled clinical trials demonstrated that P supplementation can reduce the reoccurrence of preterm birth (PTB) by 33-50% compared to placebo-treated pregnancies. These progestational agents represent the first therapy that addresses prevention of prematurity rather than optimization of care for the premature infant. The de novo synthesis of P from cholesterol in the placenta requires that cholesterol enter the mitochondria. P450 side chain cleavage (P450scc) and 3beta-hydroxysteroid dehydrogenase type I (3bHSD-1) act to convert cholesterol to P. MLN64 protein has been implicated in the initial cholesterol transport into the placental mitochondria for steroidogenesis. We hypothesize that a premature decrease in P synthesis in the placenta is a contributing factor in PTB, such that some women will need extra P to prevent PTB. Placental P450scc and 3bHSD-1 mRNA will be quantified using real-time RT-PCR and enzyme activity assays will be performed examining the conversion of cholesterol to pregnenolone and pregnenolone to progesterone, while protein levels will be assessed by western analysis and relative densitometry studies. Placental pregnenolone and P concentrations will be measured. MLN64 and its proteolytic variants which can enhance steroidogenesis will be studied in these same specimens by western analysis.The PTB and the 17P treated groups will be compared to gestationally age matched controls. We expect that decreased expression of the P pathway will be seen in women who respond successfully to 17P in preventing recurrent PTB. Determining the mechanism of 17P will allow therapy to specific women who are at risk for PTB without overtreatment of women who cannot respond.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Placental progesterone biosynthesis in preterm pregnancy
-
批准号:7599758
-
项目类别:
-
资助金额:$6.51万
-
财政年份:2005
-
负责人:Eileen Yee Wang
-
依托单位:
Placental progesterone biosynthesis in preterm pregnancy
-
批准号:6964461
-
项目类别:
-
资助金额:$7.63万
-
财政年份:2005
-
负责人:Eileen Yee Wang
-
依托单位:
ACTIVIN A IN HUMAN PREGNANCY
-
批准号:6245179
-
项目类别:
-
资助金额:$1.2万
-
财政年份:1997
-
负责人:Eileen Yee Wang
-
依托单位:
国内基金
海外基金
登录
查看更多内容
胆固醇合成蛋白CYP51介导线粒体通透性转换诱发Th17/Treg细胞稳态失衡在舍格伦综合征中的作用机制研究
-
批准号:82370976
-
项目类别:面上项目
-
资助金额:48.00万元
-
批准年份:2023
-
负责人:郑凌艳
-
依托单位:
海马神经元胆固醇代谢重编程致染色质组蛋白乙酰化水平降低介导老年小鼠术后认知功能障碍
-
批准号:82371192
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:田婕
-
依托单位:
PDLIM3-Cholesterol-SMO轴调控SHH通路激活及其在髓母细胞瘤中的功能研究
-
批准号:82072798
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2020
-
负责人:张丽
-
依托单位:
以促内涵体逃逸聚合物PEG-P[Asp(TEP)]-cholesterol为载体构建双级脑靶向基因传递系统沉默BACE1基因的研究
-
批准号:81302714
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2013
-
负责人:俞媛
-
依托单位: